Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical data support clinical testing of AVEO antibody

April 17, 2012

Exelixis discovers new PI3Kdelta inhibitors

April 17, 2012

Novel Astellas histone deacetylase inhibitor has encouraging pharmacokinetics

April 16, 2012

AbGenomics presents antibody conjugates with anticancer activity

April 16, 2012

Gliolan gets Australian orphan drug status

April 16, 2012

Antimitotic cancer therapy shows promise in vivo and in vitro

April 16, 2012

New cancer immunotherapy targets ALK-1 and VEGF pathways

April 16, 2012

New candidate cancer therapies under development at AstraZeneca

April 16, 2012

Merck & Co. presents novel PDK1 inhibitors

April 16, 2012

Exelixis reports novel PI3K-delta inhibitors

April 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...